<DOC>
	<DOCNO>NCT00346567</DOCNO>
	<brief_summary>The aim study find short course alternative single dose ( sd ) nevirapine prevention mother-to-child HIV-transmission better degree transmission protection sd nevirapine less NNRTI resistance development .</brief_summary>
	<brief_title>Backup With Combivir Single Dose ( SD ) Truvada Order Avoid Non-nucleoside Reverse Transcriptase Inhibitor ( NNRTI ) Resistance After SD Nevirapine Prevention Mother-to-child Transmission ( PMTCT )</brief_title>
	<detailed_description>Randomised open study compare Zidovudine 28 week gestation , single dose Nevirapine + 1 week Combivir Zidovudine 28 week gestation , single dose Nevirapine + single dose Truvada mother birth . In arm infant receive one dose nevirapine within first day births well 7 28 day Zidovudine . N = 450 . The study conduct Ngamiani Makorora Health Centres Bombo Regional Hospital Tanga , Tanzania cooperation Rigshospitalet , Denmark , University Copenhagen National Institute Medical Research , Tanzania .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Nevirapine</mesh_term>
	<mesh_term>Emtricitabine , Tenofovir Disoproxil Fumarate Drug Combination</mesh_term>
	<mesh_term>Reverse Transcriptase Inhibitors</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<mesh_term>Emtricitabine</mesh_term>
	<mesh_term>Lamivudine , zidovudine drug combination</mesh_term>
	<mesh_term>Lamivudine</mesh_term>
	<mesh_term>Tenofovir</mesh_term>
	<criteria>HIV infect , antiretroviral naive , fulfilling national Tanzanian criterion HAART treatment , give informed consent , consent homevisitfollowup case noshow schedule hospital visit . CD4 le 350 x10 ( 6 ) /L , suffer systemic disease need medical treatment e.g . TB , renal liver failure etc . Creatinin high 1,5 mg/dL , Alanine aminotransferase 140 U/L</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>mother-to-child-transmission</keyword>
	<keyword>PMTCT</keyword>
	<keyword>HIV</keyword>
	<keyword>resistance</keyword>
	<keyword>NNRTI</keyword>
</DOC>